Przejdź do zawartości
Merck

Beneficial effect of crotamine in the treatment of myasthenic rats.

Muscle & nerve (2013-03-06)
Saraguaci Hernandez-Oliveira e Silva, Sandro Rostelato-Ferreira, Thomaz Augusto Alves Rocha-e-Silva, Priscila Randazzo-Moura, Cháriston André Dal-Belo, Eladio Flores Sanchez, Caroline R Borja-Oliveira, Léa Rodrigues-Simioni
ABSTRAKT

Crotamine is a basic, low-molecular-weight peptide that, at low concentrations, improves neurotransmission in isolated neuromuscular preparations by modulating sodium channels. In this study, we compared the effects of crotamine and neostigmine on neuromuscular transmission in myasthenic rats. We used a conventional electromyographic technique in in-situ neuromuscular preparations and a 4-week treadmill program. During the in-situ electromyographic recording, neostigmine (17 μg/kg) caused short-term facilitation, whereas crotamine induced progressive and sustained twitch-tension enhancement during 140 min of recording (50 ± 5%, P < 0.05). On the treadmill evaluation, rats showed significant improvement in exercise tolerance, characterized by a decrease in the number of fatigue episodes after 2 weeks of a single-dose treatment with crotamine. These results indicate that crotamine is more efficient than neostigmine for enhancing muscular performance in myasthenic rats, possibly by improving the safety factor of neuromuscular transmission.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Neostigmine methyl sulfate
Neostigmine methyl sulfate, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Neostigmine bromide, ≥98% (HPLC and titration), powder